Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with interstitial lung disease (ILD):
- People aged between 40 and 80 years old
- People who have been diagnosed by a specialist team with one of the following lung conditions: idiopathic pulmonary fibrosis (IPF), a type of lung scarring called fibrotic NSIP, chronic hypersensitivity pneumonitis (HP), or an unclassified ILD that could be one of these conditions (confirm with trial site)
- People whose lung scans show signs of scarring or structural lung changes
- People considered suitable for a pulmonary rehabilitation program (a supervised exercise and education program for lung conditions)
- People able to walk at least 50 metres in a 6-minute walk test
- People whose blood oxygen level is 92% or higher when resting and breathing normal room air
- People whose condition has been stable for at least the past 6 weeks
- People who can read and write in English fluently
For healthy volunteers (control group):
- People aged between 40 and 80 years old
- People with normal lung function test results
- People with no known lung or heart disease
- People who can read and write in English fluently
Who may not be able to join:
For people with interstitial lung disease (ILD):
- People for whom exercise testing is considered unsafe, for example due to significant heart, muscle, bone, or nerve conditions
- People with other serious conditions outside the lungs that could affect their ability to exercise or maintain oxygen levels
- People whose lung function test results fall below certain thresholds (confirm specific values with trial site)
- People who have taken part in a pulmonary rehabilitation program in the past 6 months, or are currently doing so
- People who have taken prednisone (a steroid medication) at a dose greater than 10 mg per day for more than 2 weeks within the 3 months before the first study visit
- People with significant emphysema (a separate type of lung condition), based on scan or breathing test results
For healthy volunteers (control group):
- People who currently smoke, or who have a significant smoking history (more than 10 pack-years)
- People with any medical condition that prevents safe participation in exercise
- People who have a cardiac pacemaker or any metal or electronic device inside their body
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jordan A Guenette, PhD, University of British Columbia
Phone: 1-604-806-8835
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in standardized dyspnea score during the constant load exercise test (visit 3); Change in standardized dyspnea score during the constant load exercise test (visit 4); Change in leg muscle strength measured following the constant load exercise test (visit 3); Change in leg muscle strength measured following the constant load exercise test (visit 4)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.